Navigation Links
2 Cleveland Clinic researchers honored for contribution to science
Date:11/25/2013

Monday, Nov. 25, 2013, Cleveland: Cleveland Clinic researchers Richard A. Padgett, Ph.D., and Edward F. Plow, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS). This year's AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on Nov. 29, 2013.

Dr. Padgett, who works in the Department of Molecular Genetics at the Lerner Research Institute, was elected as an AAAS Fellow for distinguished contributions to the field of RNA processing, particularly in the areas of RNA splicing, the diversity of splicing mechanisms, and connections with disease.

RNA, or ribonucleic acid, is a nucleic acid present in all living cells that translates the genetic code (DNA) into proteins. RNA splicing is the processing of RNA to remove portions that do not encode proteins. Many diseases are either caused by or associated with mistakes in the splicing process or mutations in the splicing machinery. Dr. Padgett's research aims to understand how these errors in RNA splicing lead to disease, such as cancer, and how the errors can be corrected.

Dr. Plow, Department Chair of Molecular Cardiology at the Lerner Research Institute, and The Robert C. Tarazi, M.D., Endowed Chair in Heart and Hypertension Research, is being honored as an AAAS Fellow for distinguished contributions to vascular biology, particularly for elucidating mechanisms of platelets, integrins, and plasminogen, and outstanding services to the cardiovascular community.

Dr. Plow's research involves dissecting the cellular mechanisms underlying hypertension and heart disease. Specifically, he studies the role of integrins, a type of cell adhesion molecule involved in blood coagulation, in cardiovascular disease. He also recently discovered that the blood protein plasminogen, which has long been associated with coronary artery disease, and a related enzyme are essential in the formation of foam cells-- a hallmark of advanced atherosclerosis, or hardening of the arteries.

Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers. This year 388 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications.


'/>"/>

Contact: Laura Ambro
ambrol@ccf.org
216-636-5876
Cleveland Clinic
Source:Eurekalert

Related biology news :

1. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
2. Cleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer
3. Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients
4. Cleveland Clinic researchers discover new link between heart disease and red meat
5. Cleveland Clinic research shows gut bacteria byproduct predicts heart attack and stroke
6. Cleveland Clinics 2013 Obesity Summit explores causes, prevention and treatment of obesity
7. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. New clinical trial explores novel noninvasive colon cancer screening test
10. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: